|Bid||0.00 x 3100|
|Ask||0.00 x 1800|
|Day's Range||6.39 - 6.93|
|52 Week Range||5.30 - 62.88|
|Beta (5Y Monthly)||1.33|
|PE Ratio (TTM)||30.23|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Aurora Cannabis (NYSE: ACB), once a favorite among pot investors because of its bold expansion strategy, lost steam in 2019. Aurora's shares declined 56% last year, compared to a 36% decline of the industry benchmark, the Horizons Marijuana Life Sciences Index ETF. Marijuana sales have been rising in 2020, particularly because of the coronavirus pandemic, which has amplified consumer demand.
When you think about marijuana stocks, popular Canadian cannabis companies including Aurora Cannabis (NYSE: ACB) and Canopy Growth (NYSE: CGC) likely come to mind. Illinois-based Cresco Labs (OTC: CRLBF) had an impressive start to the year with its first-quarter results, and it continued to shine with its stunning second-quarter results, reported on Aug. 20. Shares of Cresco are down 20% so far this year, while Aurora's and Canopy's shares have lost 73% and 22%, respectively.
Investors hope that the popular pot stock will recover this year. But in order for that to happen, it has to get a lot right.